â 1-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder , Smith-Magenis syndrome

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sleep problems in children with mental handicap.

  2008cited by this paper
• Diagnosis And Treatment Of Hypertension In Children And Adolescents

  2003cited by this paper
• Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.

  2001cited by this paper
• The suprachiasmatic nucleus and the circadian time-keeping system revisited.

  2000cited by this paper
• Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome

  2000cited by this paper
• Influence of beta-blockers on melatonin release

  1999cited by this paper
• The face of Smith-Magenis syndrome: a subjective and objective study

  1999cited by this paper
• Effects of a Low Dose of Melatonin on Sleep in Children with Angelman Syndrome

  1999cited by this paper
• Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment

  1998cited by this paper
• Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2).

  1998cited by this paper
• Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).

  1998cited by this paper
• A comparison of psychological and pharmacological treatment of pediatric migraine.

  1998cited by this paper
• Sleep-inducing effects of exogenous melatonin administration.

  1998cited by this paper
• Circadian rhythms: basic neurobiology and clinical applications.

  1997cited by this paper
• The effect of atenolol, a p!‐adrenergic antagonist, on nocturnal plasma melatonin secretion: Evidence for a dose‐response relationship in humans

  1997cited by this paper
• Use of melatonin in the treatment of paediatric sleep disorders

  1996cited by this paper
• SLEEP PATTERNS IN CHILDREN AND YOUNG ADULTS WITH MENTAL RETARDATION AND SEVERE BEHAVIOR DISORDERS

  1996cited by this paper
• Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients.

  1996cited by this paper
• Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2)

  1996cited by this paper
• Melatonin possesses time-dependent hypnotic effects.

  1994cited by this paper
• Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages.

  1992cited by this paper
• Interstitial deletion of (17)(p11.2p11.2) in nine patients.

  1986cited by this paper

• Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review

  2023cites this paper
• Caregivers’ experience of sleep management in Smith–Magenis syndrome: a mixed-methods study

  2022cites this paper
• Pharmacologic Approaches to Insomnia and Other Sleep Disorders in Children

  2022cites this paper
• Circadian disruption and human health.

  2021cites this paper
• Smith‐Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort

  2021cites this paper
• Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review

  2021cites this paper
• Neurodevelopmental Disorders Commonly Presenting with Sleep Disturbances

  2021cites this paper
• Relationship between rosacea and sleep

  2020cites this paper
• The Feasibility and Outcomes of Genetic Testing for Autism and Neurodevelopmental Disorders on an Inpatient Child and Adolescent Psychiatry Service

  2020cites this paper
• Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder

  2019influential citation
• Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders

  2019cites this paper
• Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review.

  2018cites this paper
• Rhythms of life: circadian disruption and brain disorders across the lifespan

  2018cites this paper
• Melanopsin System Dysfunction in Smith-Magenis Syndrome Patients.

  2018cites this paper
• Sleep Disorders in Childhood Neurogenetic Disorders

  2017cites this paper
• Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review

  2016cites this paper
• Smith-Magenis syndrome and its circadian influence on development, behavior, and obesity - own experience.

  2015cites this paper
• Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith–Magenis and Potocki–Lupski Syndromes

  2015cites this paper
• Behavioral disturbance and treatment strategies in Smith-Magenis syndrome

  2015cites this paper
• Acebutolol and Immediate Release Melatonin in Treatment of Smith-Magenis Syndrome

  2015cites this paper
• Nutrition and Nutraceutical Supplements for the Treatment of Hypertension: Part III

  2013cites this paper
• The role of nutrition and nutraceutical supplements in the prevention and treatment of hypertension

  2013cites this paper
• Circadian abnormalities in mouse models of smith–magenis syndrome: Evidence for involvement of RAI1

  2013cites this paper
• The nature of social preference and interactions in Smith-Magenis syndrome.

  2013cites this paper
• Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders

  2013cites this paper
• Daytime somnolence in an adult with smith–magenis syndrome

  2013cites this paper
• An Indirect Examination of the Function of Problem Behavior Associated with Fragile X Syndrome and Smith-Magenis Syndrome

  2012cites this paper
• Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith–Magenis syndrome

  2011cites this paper
• An Indirect Examination of the Function of Problem Behavior Associated with Fragile X Syndrome and Smith-Magenis Syndrome

  2011cites this paper
• Psychopharmacology in children with intellectual disability

  2011cites this paper
• An assessment of obesity and hyperphagia in individuals with Smith-Magenis syndrome

  2010cites this paper
• Epigenetics, Copy Number Variation, and Other Molecular Mechanisms Underlying Neurodevelopmental Disabilities: New Insights and Diagnostic Approaches

  2010cites this paper
• The Mechanism of Obesity in Rai1+/- Mice

  2010cites this paper
• Role of Individual Subunits of the Neurospora crassa CSN Complex in Regulation of Deneddylation and Stability of Cullin Proteins

  2010cites this paper
• Posttraumatic Stress Disorder and Phenotype- Specific Challenging Behavior in an Individual With Smith-Magenis Syndrome: A Multimodal Approach

  2009influential citation
• In association with Smith – Magenis syndrome

  2008cites this paper
• Gender, genotype, and phenotype differences in Smith–Magenis syndrome: a meta‐analysis of 105 cases

  2007cites this paper
• Adaptive and Maladaptive Behavior in Children with Smith-Magenis Syndrome

  2006cites this paper
• Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome.

  2006cites this paper
• Circadian clock genes in mammalian clockwork, metabolism and behaviour

  2005cites this paper
• Importance and Relevance of Melatonin to Human Biological Rhythms

  2003cites this paper
• Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2).

  2003cites this paper
• RUNNING HEAD: PROBLEM BEHAVIOR IN FRAGILE X AND SMITH-MAGENIS SYNDROME An Indirect Examination of the Function of Problem Behavior Associated with Fragile X Syndrome and Smith-Magenis Syndrome

  year unknowncites this paper